| Primary |
| Breast Cancer |
20.3% |
| Product Used For Unknown Indication |
20.3% |
| Breast Cancer Metastatic |
15.8% |
| Prophylaxis |
4.9% |
| Nausea |
4.8% |
| Pain |
4.7% |
| Drug Use For Unknown Indication |
4.4% |
| Pancreatic Carcinoma |
4.2% |
| Hypertension |
3.5% |
| Non-small Cell Lung Cancer |
2.7% |
| Constipation |
2.3% |
| Vomiting |
1.7% |
| Head And Neck Cancer |
1.5% |
| Metastatic Malignant Melanoma |
1.4% |
| Pancreatic Carcinoma Metastatic |
1.4% |
| Ovarian Cancer |
1.4% |
| Diabetes Mellitus |
1.3% |
| Gastric Cancer |
1.2% |
| Anxiety |
1.1% |
| Abdominal Pain |
1.0% |
|
| Death |
32.5% |
| Vomiting |
13.0% |
| White Blood Cell Count Decreased |
7.4% |
| Sepsis |
4.4% |
| Pancreatic Carcinoma |
4.2% |
| Syncope |
3.6% |
| Neutropenia |
3.3% |
| Pneumonia |
3.2% |
| Macular Oedema |
3.0% |
| Thrombocytopenia |
3.0% |
| Pleural Effusion |
2.4% |
| Decreased Appetite |
2.3% |
| Diarrhoea |
2.3% |
| Nausea |
2.3% |
| Neuropathy Peripheral |
2.3% |
| Neutrophil Count Decreased |
2.3% |
| Pulmonary Embolism |
2.3% |
| General Physical Health Deterioration |
2.1% |
| Interstitial Lung Disease |
2.1% |
| Febrile Neutropenia |
2.0% |
|
| Secondary |
| Breast Cancer Metastatic |
17.4% |
| Breast Cancer |
15.4% |
| Drug Use For Unknown Indication |
11.1% |
| Product Used For Unknown Indication |
10.5% |
| Nausea |
7.1% |
| Hypertension |
5.1% |
| Non-small Cell Lung Cancer |
4.9% |
| Pain |
4.5% |
| Prophylaxis |
4.3% |
| Constipation |
3.8% |
| Metastases To Bone |
2.3% |
| Vomiting |
2.1% |
| Head And Neck Cancer |
2.1% |
| Vitamin Supplementation |
1.6% |
| Parkinson's Disease |
1.4% |
| Ovarian Cancer |
1.3% |
| Pancreatic Carcinoma |
1.3% |
| Anaemia |
1.2% |
| Anxiety |
1.2% |
| Insomnia |
1.2% |
|
| Vomiting |
13.0% |
| White Blood Cell Count Decreased |
9.8% |
| Macular Oedema |
9.2% |
| Pyrexia |
8.6% |
| Subcutaneous Abscess |
6.3% |
| Syncope |
5.7% |
| Thrombocytopenia |
4.1% |
| Cystoid Macular Oedema |
3.8% |
| Hypotension |
3.8% |
| Mucosal Inflammation |
3.8% |
| Neutropenia |
3.8% |
| Neutrophil Count Decreased |
3.8% |
| Death |
3.5% |
| Pleural Effusion |
3.2% |
| Sepsis |
3.2% |
| Weight Decreased |
3.2% |
| Metastases To Central Nervous System |
2.9% |
| Pain |
2.9% |
| Pneumonia |
2.9% |
| C-reactive Protein Increased |
2.5% |
|
| Concomitant |
| Breast Cancer Metastatic |
23.0% |
| Breast Cancer |
21.4% |
| Drug Use For Unknown Indication |
9.4% |
| Metastases To Bone |
8.1% |
| Product Used For Unknown Indication |
7.9% |
| Breast Cancer Female |
4.2% |
| Premedication |
3.1% |
| Depression |
2.9% |
| Pain |
2.7% |
| Small Intestine Carcinoma |
2.4% |
| Anxiety |
2.3% |
| Chemotherapy |
1.9% |
| Anaemia |
1.5% |
| Constipation |
1.5% |
| Prophylaxis |
1.5% |
| Breast Cancer Recurrent |
1.3% |
| Diabetes Mellitus |
1.3% |
| Resorption Bone Increased |
1.3% |
| Ovarian Cancer |
1.2% |
| Osteoporosis |
1.1% |
|
| Weight Decreased |
11.4% |
| Death |
9.5% |
| Disease Progression |
8.6% |
| Wheelchair User |
7.7% |
| Walking Aid User |
6.4% |
| Toothache |
5.0% |
| Vomiting |
4.5% |
| Wheezing |
4.5% |
| Vertebroplasty |
4.1% |
| Wound Complication |
4.1% |
| Diarrhoea |
3.6% |
| Hepatic Cirrhosis |
3.6% |
| Osteonecrosis |
3.6% |
| Pleural Effusion |
3.6% |
| Vision Blurred |
3.6% |
| White Blood Cell Count Decreased |
3.6% |
| Wound Infection Staphylococcal |
3.6% |
| Wound Drainage |
3.2% |
| Metastases To Liver |
2.7% |
| Throat Irritation |
2.7% |
|
| Interacting |
|
| Peripheral Sensory Neuropathy |
100.0% |
|
